Study finds long-term eczema treatment benefits patients with delayed response

New research from the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai reveals that patients with moderate-to-severe atopic dermatitis (eczema) who did not initially respond to biologic treatment may still achieve significant clinical improvements with continued therapy.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup